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Available online 23 April 2016The emergence and distribution of drug resistance in malaria are serious public health concerns in tropical and
subtropical regions of the world. However, the molecular mechanism of drug resistance remains unclear. In
the present study, we performed a high-throughput RNA-Seq to identify and characterize the differentially
expressed genes between the chloroquine (CQ) sensitive (3D7) and resistant (Dd2) strains of Plasmodium
falciparum. The parasite cells were cultured in the presence and absence of CQ by in vitro method. Total RNA
was isolated from the harvested parasite cells using TRIzol, and RNA-Seq was conducted using an Illumina
HiSeq 2500 sequencing platformwith paired-end reads and annotated using Tophat. The transcriptome analysis
of P. falciparum revealed the expression of ~5000 genes, in which ~60% of the genes have unknown function.
Cuffdiff program was used to identify the differentially expressed genes between the CQ-sensitive and resistant
strains. Here, we furnish a detailed description of the experimental design, procedure, and analysis of the
transcriptome sequencing data, that have been deposited in the National Center for Biotechnology Information
(accession nos. PRJNA308455 and GSE77499).
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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. This is an open access article under1. Direct link to deposited data
The rawdata have been deposited in the BioProject database of NCBI
with the accession no PRJNA308455 (http://www.ncbi.nlm.nih.gov/
bioproject/308455). The processed data have been submitted in
NCBI under the Gene Expression Omnibus (GEO) with the accession
no GSE77499 (http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?
acc=GSE77499).
2. Experimental design, materials and methods
2.1. Experimental design
Drug resistance in Plasmodium falciparum is a challenging major
problem around the world. The ﬁrst drug resistance was reported in
1960 for the therapeutic drug, chloroquine, which is cost-effective and
available easily [1]. Since then many reports have been documented
for various antimalarial drugs and reverse the decreased mortality and
morbidity rate achieved through malaria control program. To better
understand the genes involved in drug resistance and molecular
mechanism, we conducted a high-throughput RNA-Seq for the chloro-
quine (CQ) sensitive and resistant strains of P. falciparum. Also, thethe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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changes in gene expression in exposure to the drug.
2.2. Cell culture
The laboratory adapted chloroquine sensitive (3D7), and resistant
(Dd2) strains of P. falciparum were cultured continuously by in vitro
technique as described [2]. The parasite cells were grown in ‘O+’ red
blood cells at 1–5% parasitemia with 5% hematocrit in RPMI 1640
(Gibco) media supplemented with 5% Albumax (Gibco), 25 mM
HEPES buffer, 2.1 g/L sodium bicarbonate, 0.05% hypoxanthine
(Sigma), and 200 μg/mL gentamycin. Synchronization of the parasite
cells was carried out when the parasitemia reaches ~10% using 5% D-
Sorbitol (Sigma). The synchronized cells were maintained further
and harvested at 48 h with 5% parasitemia containing ~90% tropho-
zoites. P. falciparum Dd2 strain was cultured and harvested in the
presence of minimum inhibitory concentration of CQ (160 nM/L)
[3], in addition to the above-described growth condition. The growth
of the Dd2 strain was reduced in the presence of CQ when compared
to their growth in the absence of CQ.
2.3. RNA isolation and quality control
Total RNA was isolated from the harvested parasite cells with
RNAiso Plus reagent (Takara, Japan), based on the manufacturer's in-
struction. The concentration of the isolated RNA was quantiﬁed using
Nanodrop (Thermo Scientiﬁc, USA) and Qubit (Invitrogen, USA), and
integrity of the RNAwasmeasured by a 2100 Bioanalyzer (Agilent Tech-
nologies, CA).
2.4. RNA-Seq and assembly
Paired-end sequencing cDNA libraries were constructed from the
three samples using a TruSeq RNA Sample Preparation Kit v2 low
sample (LS) protocol (Illumina Inc., CA), based on themanufacturer's in-
structions. RNA-Seqwas conducted for the three libraries on an Illumina
HiSeq 2500 system (Illumina Inc., CA) with 2× coverage [4]. The data
quality of the fastq ﬁles was checkedwith FastQC tool (BabrahamBioin-
formatics) and the reads with ≥30 Phred quality score were taken into
account for analysis. The processed paired-end reads were mapped to
the reference P. falciparum genome available in the Ensemble Genome
database (Release 26) using Tophat program version 2.0.8 [4,5]. The
numbers of paired-reads mapped to the reference genome were asFig. 1. Volcano plot for the signiﬁcantly expressefollows: 37,469,173 (3D7, CQ-sensitive; 85.4%), 35,650,111 (Dd2,
CQ-resistant; 89.1%) and 20,856,492 (Dd2w/CQ, cultured in 160 nM
CQ; 84%).2.5. Annotation and differential expression analysis
The mapped reads were assembled using the cufﬂinks program
(version 2.0.2)with default parameters [5], to determine gene and tran-
script expression. The differentially expressed genes were determined
with the p-value ≤0.05 between the CQ-sensitive (3D7, control) and re-
sistant (Dd2 and Dd2w/CQ, test) strains using the cuffdiff tool in the
cufﬂinks program. The differentially expressed genes were character-
ized further based on gene ontology enrichment using the strategy
tool in the PlasmoDB database [6]. The volcano plot describing the sig-
niﬁcantly up and down-regulated genes between the 3D7, Dd2 and
Dd2w/CQ strains is shown in Fig. 1. The cuffdiff analysis has identiﬁed
a total of 316 differentially expressed genes of which 89 and 227
genes were up and down-regulated respectively between the 3D7 and
Dd2 strains. Similarly, a total of 454 geneswere differentially expressed,
in which 45 and 409 genes were up down-regulated genes between the
3D7 and Dd2w/CQ strains. Most of the genes encoding for surface anti-
gens involved in invasion, pathogenesis, showed a signiﬁcant difference
in gene expression between the sensitive and resistant strains.Conﬂict of interest
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